Director, Global Integrated Insights – HIV

Director, Global Integrated Insights – HIV

The Director, Global Integrated Insights HIV in Gilead’s Global Decision Sciences & Insights (GDSI) group participates actively in Commercial efforts by providing an objective and detailed understanding of current and future markets, product performance, customers, and competitors. This individual must possess a broad skill set (e.g. functional expertise, therapeutic knowledge, communication skills, etc.) to ensure efficient execution of GDSI objectives with a diverse set of key stakeholders – including Global Strategic Marketing (GSM), Clinical Development, Corporate Development, Commercial Strategy, functional Commercial Operations counterparts, Project & Portfolio Management and global Commercial leadership.

This role will have global responsibility for generating foundational market understanding in the HIV Treatment space through the execution of market research and forecasting/analytics in key commercial markets (i.e. US, EU4+UK, Japan, and China).

• Analyze secondary data sources (e.g., prescription data, epidemiology studies) to generate insights and identify implications
• Forecasting/Analytics Related to Pipeline Planning, Opportunity Assessments, Global Marketing and Business Development
• Scope, design, and manage the execution of quantitative market research (e.g., discrete-choice conjoint) to inform revenue forecasting
• Develop long‑term (i.e. 10‑year) strategic forecasts for pipeline and marketed products that incorporate disease epidemiology, evolving treatment paradigms, competitive products and global pricing and access dynamics
• Collaborate with internal experts in Market Research, Literature Resources, Competitive Intelligence, R&D, and Marketing/Sales leads to generate robust forecast assumptions
• Conduct forecast scenario analysis to support decision‑making by Commercial, R&D, Corporate Development, Finance, and corporate executive leadership

• Deep expertise with IQVIA Claims, SDOH/Consumer Data, Lab Data, and patient chart audits
• Solid understanding of ex‑US data limitations and creativity to perform analytics with limited data and triangulate insights across data sources
• Co‑develop and partner with Advanced Analytics in development and application of predictive sciences/modeling to deeply understand stakeholder insights related to patient journeys, physician treatment processes, institutional and provider decision making, etc. and brand interventional strategies for both US and ex‑US
• Other examples of work can include but are not limited to brand driver analyses, performance assessments, treatment flow mapping, segmentation, patient and HCP journey mapping, etc.

• Define Global market research priorities in collaboration with Global Strategic Marketing (GSM) Indication and/or Therapeutic Area Leads to proactively address key business needs; research for Launch Planning, Unbranded/Branded Campaign development, and launch execution
• Create market understanding through the development of treatment flow maps, market segmentation, attribute/benefit testing, positioning, messaging, and campaign development, etc.
• Manage vendors to determine appropriate research methodology, ensure project alignment to business objectives and guide execution and reporting
• Evaluating potential new secondary data sources, to rationalize against array of data sources currently used by Gilead

• Communicate results of market research and forecasting/analytics to a variety of internal stakeholders at all levels of the organization
• Develop clear and effective communication materials (e.g. reports, presentations)
• Work with Global Strategic Marketing (GSM) Indication and/or Therapeutic Area Leads to understand implications of market research and forecasting/analytics insights for Gilead’s business, and develop plans to address these implications

• Bachelor's Degree and Twelve Years’ Experience
• Masters’ Degree and Ten Years’ Experience
• PhD and Eight Years’ Experience

• BA/BS degree with experience in life sciences, pharma or biotech is required, and an…